Quick Answer
Sanara MedTech Inc. reported Total Revenue of $103.12 million for fiscal year 2025.
Sanara MedTech Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $103.12M +19.0% |
$86.67M +33.4% |
$64.99M +41.8% |
$45.84M +89.9% |
$24.14M +54.9% |
$15.59M +32.5% |
| Revenue (ASC 606) | $103.12M +19.0% |
$86.67M +33.4% |
$64.99M +41.8% |
$45.84M +89.9% |
$24.14M +54.9% |
$15.59M |
| Net Income | -$37.56M -288.7% |
-$9.66M -124.6% |
-$4.30M +45.8% |
-$7.94M -0.2% |
-$7.92M -78.2% |
-$4.45M -58.0% |
| Diluted EPS | -$4.36 -282.5% |
-$1.14 -119.2% |
-$0.52 +48.0% |
-$1.00 | — | -$0.76 +42.4% |
| Total Assets | $72.94M -17.2% |
$88.09M +19.3% |
$73.87M +21.0% |
$61.04M +67.7% |
$36.40M +270.4% |
$9.83M -11.6% |
| Cash and Equivalents | $16.58M +4.4% |
$15.88M +208.5% |
$5.15M -42.5% |
$8.96M -52.0% |
$18.65M +3996.2% |
$455.4K -93.1% |
| Long-Term Debt | $45.97M +49.8% |
$30.69M +236.8% |
$9.11M | — | — | — |
| Stockholders Equity | $5.94M -84.9% |
$39.40M -12.1% |
$44.83M +7.2% |
$41.83M +36.5% |
$30.64M +398.2% |
$6.15M -7.0% |
| R&D Expense | $5.07M +79.3% |
$2.83M -31.5% |
$4.13M +22.7% |
$3.37M +502.7% |
$558.7K +1290.2% |
$40.2K |
| Operating Income | $7.30M +480.3% |
$1.26M +129.9% |
-$4.22M +66.3% |
-$12.52M -69.7% |
-$7.38M -46.5% |
-$5.03M -83.7% |
| Gross Profit | $95.60M +21.7% |
$78.53M +37.4% |
$57.14M +44.7% |
$39.48M +80.8% |
$21.83M +56.3% |
$13.97M +32.3% |
| Shares Outstanding | 8.95M +2.2% |
8.75M +2.6% |
8.54M +2.8% |
8.30M +8.1% |
7.68M +21.9% |
6.30M +76.3% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $26.33M | +21.5% | +1.9% |
| Revenue (ASC 606) | September 30, 2025 | $26.33M | +21.5% | +1.9% |
| Net Income | September 30, 2025 | -$30.41M | -964.2% | -1409.7% |
| Diluted EPS | September 30, 2025 | -$3.40 | -900.0% | -1378.3% |
| Total Assets | September 30, 2025 | $71.09M | -19.7% | -28.0% |
| Cash and Equivalents | September 30, 2025 | $14.94M | -8.2% | -11.9% |
| Long-Term Debt | September 30, 2025 | $45.09M | +49.9% | +2.0% |
| Stockholders Equity | September 30, 2025 | $6.15M | -84.5% | -82.6% |
| R&D Expense | September 30, 2025 | $1.03M | +31.4% | -18.1% |
| Operating Income | September 30, 2025 | $2.94M | +277.8% | +9482.5% |
| Gross Profit | September 30, 2025 | $24.46M | +24.3% | +2.4% |
| Shares Outstanding | September 30, 2025 | 8.93M | +2.1% | +0.3% |
- Sanara MedTech Inc. reported Total Revenue of $103.12 million for fiscal year 2025.
- Sanara MedTech Inc. showed an increase of +19.0% in Total Revenue compared to the prior fiscal year.
- Sanara MedTech Inc. reported Revenue (ASC 606) of $103.12 million for fiscal year 2025.
- Sanara MedTech Inc. showed an increase of +19.0% in Revenue (ASC 606) compared to the prior fiscal year.
- Sanara MedTech Inc. reported Net Income of -$37.56 million for fiscal year 2025.
- Sanara MedTech Inc. showed a decrease of -288.7% in Net Income compared to the prior fiscal year.
- Sanara MedTech Inc. reported Diluted EPS of $4.36 per share (loss) for fiscal year 2025.
- Sanara MedTech Inc. showed a decrease of -282.5% in Diluted EPS compared to the prior fiscal year.
- Sanara MedTech Inc. reported Total Assets of $72.94 million for fiscal year 2025.
- Sanara MedTech Inc. showed a decrease of -17.2% in Total Assets compared to the prior fiscal year.
- Sanara MedTech Inc. reported Cash and Equivalents of $16.58 million for fiscal year 2025.
- Sanara MedTech Inc. showed an increase of +4.4% in Cash and Equivalents compared to the prior fiscal year.
- Sanara MedTech Inc. reported Long-Term Debt of $45.97 million for fiscal year 2025.
- Sanara MedTech Inc. showed an increase of +49.8% in Long-Term Debt compared to the prior fiscal year.
- Sanara MedTech Inc. reported Stockholders Equity of $5.94 million for fiscal year 2025.
- Sanara MedTech Inc. showed a decrease of -84.9% in Stockholders Equity compared to the prior fiscal year.
- Sanara MedTech Inc. reported R&D Expense of $5.07 million for fiscal year 2025.
- Sanara MedTech Inc. showed an increase of +79.3% in R&D Expense compared to the prior fiscal year.
- Sanara MedTech Inc. reported Operating Income of $7.30 million for fiscal year 2025.
- Sanara MedTech Inc. showed an increase of +480.3% in Operating Income compared to the prior fiscal year.
- Sanara MedTech Inc. reported Gross Profit of $95.60 million for fiscal year 2025.
- Sanara MedTech Inc. showed an increase of +21.7% in Gross Profit compared to the prior fiscal year.
- Sanara MedTech Inc. reported Shares Outstanding of 8.95 million shares for fiscal year 2025.
- Sanara MedTech Inc. showed an increase of +2.2% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: